Clinical Trials Insight: 700029950
Phase of Trial: Phase III
Latest Information Update: 23 Apr 2008
At a glance
- Drugs Renzapride (Primary)
- Indications Irritable bowel syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Alizyme
- 06 Mar 2008 Recruitment is expected to commence following conclusion of a commercial deal, according to a Alizyme media release.
- 18 Jan 2008 New trial record.